Sandro Zambito Marsala
Research Subjects
Sandro Zambito Marsala has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Manuela Gioulis
Department of Neurology, Ospedale San Martino di Belluno (BL), Viale Europa 22, CAP 32100, Belluno, Italy
12 shared publicationsCorrado Marchini
San Martino Hospital
7 shared publications- Michele Pistacchi
Santorso Hospital
7 shared publications Federico Fabris
San Martino Hospital Department of Neurology, Belluno, Viale Europa 22 CAP 32100, Italy
3 shared publicationsFranco Ferracci
Ospedale San Martino Belluno
3 shared publicationsAnnalisa Fornasier
Ospedale San Martino
2 shared publications
Latest Publications
- 9 July 2016
- Published by Springer Nature in Neurological Sciences
- Vol. 37 (10) , 1707-1711
Parkinson’s disease and cerebrovascular disease: is there a link? A neurosonological case–control study
Cerebrovascular disease (CVD) and idiopathic Parkinson’s disease (PD) frequently occur in the elderly; however, CVD is not frequent in the PD population. The possible relationship between PD and CVD was studied with controversial findings. More specifically, it is unclear whether PD can be protective against the development of vascular disease. To assess the neurosonological examination of a group of PD patients matched with a control group of patients not affected by PD along with the potential risk of developing CVD in the PD group to evaluate any differences. The analysis of the left common carotid artery (CCA) revealed a mean intima-media thickness (IMT) of 0.77 ± 0.21 mm in the PD group and 0.83 ± 0.17 mm in the control group, while the right CCA mean IMT was 0.61 ± 0.17 mm in the PD patients and 0.98 ± 0.18 mm in the control group. The difference was statistically significant in both sides. PD patients show a lower IMT value in older age (70–80 years) and a reduced cardiovascular risk.
- 9 July 2016
- Published by Springer Nature in Neurological Sciences
- Vol. 37 (10) , 1707-1711
Parkinson’s disease and cerebrovascular disease: is there a link? A neurosonological case–control study
Cerebrovascular disease (CVD) and idiopathic Parkinson’s disease (PD) frequently occur in the elderly; however, CVD is not frequent in the PD population. The possible relationship between PD and CVD was studied with controversial findings. More specifically, it is unclear whether PD can be protective against the development of vascular disease. To assess the neurosonological examination of a group of PD patients matched with a control group of patients not affected by PD along with the potential risk of developing CVD in the PD group to evaluate any differences. The analysis of the left common carotid artery (CCA) revealed a mean intima-media thickness (IMT) of 0.77 ± 0.21 mm in the PD group and 0.83 ± 0.17 mm in the control group, while the right CCA mean IMT was 0.61 ± 0.17 mm in the PD patients and 0.98 ± 0.18 mm in the control group. The difference was statistically significant in both sides. PD patients show a lower IMT value in older age (70–80 years) and a reduced cardiovascular risk.
- 12 November 2015
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 116 (3) , 341-343
Facial palsy in cerebral venous thrombosis: an atypical case in adults
- 12 November 2015
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 116 (3) , 341-343
Facial palsy in cerebral venous thrombosis: an atypical case in adults
- 1 October 2015
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 357 (1-2) , 19-21
Pain perception in major depressive disorder: A neurophysiological case–control study
- 1 October 2015
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 357 (1-2) , 19-21
Pain perception in major depressive disorder: A neurophysiological case–control study
- 11 February 2015
- Published by Springer Nature in Neurological Sciences
- Vol. 36 (6) , 1011-1015
Cerebrospinal fluid and lumbar puncture: the story of a necessary procedure in the history of medicine
The aim of our work was to investigate the different historical stages that led gradually to the discovery of the anatomical structures that form and contain cerebrospinal fluid (CSF), until the Quincke idea, to collect the liquid directly at the lumbar level delivering to humanity a diagnostic tool present and absolutely irreplaceable in everyday clinical practice. This is done through consultation of all the historical medical literature, together with the critical examination of the original articles when available in the most rigorous chronological and speculative order, which enabled knowledge advancement.
- 11 February 2015
- Published by Springer Nature in Neurological Sciences
- Vol. 36 (6) , 1011-1015
Cerebrospinal fluid and lumbar puncture: the story of a necessary procedure in the history of medicine
The aim of our work was to investigate the different historical stages that led gradually to the discovery of the anatomical structures that form and contain cerebrospinal fluid (CSF), until the Quincke idea, to collect the liquid directly at the lumbar level delivering to humanity a diagnostic tool present and absolutely irreplaceable in everyday clinical practice. This is done through consultation of all the historical medical literature, together with the critical examination of the original articles when available in the most rigorous chronological and speculative order, which enabled knowledge advancement.
- 27 December 2014
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 115 (3) , 405-408
Reversible posterior leukoencephalopathy syndrome (RPLS): a report of two cases in adults
- 27 December 2014
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 115 (3) , 405-408
Reversible posterior leukoencephalopathy syndrome (RPLS): a report of two cases in adults
- Open Access
- 17 December 2013
- Published by Springer Nature in Neurology and Therapy
- Vol. 3 (1) , 41-66
Rasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease. Once daily administration of rasagiline makes it easy to use, and allows good compliance by patients and adherence to therapy. Several multicenter studies have noted the effectiveness of rasagiline on both motor and non-motor symptoms, which require a complex pharmacologic approach, such as cognitive disorders. A recent study also reported a rapid action of rasagiline on motor symptoms. Positive findings have been highlighted by an economic model study. This review analyzes the main studies of rasagiline, with particular attention to the effectiveness of the drug on motor symptoms.
- 17 December 2013
- Published by Springer Nature in Neurology and Therapy
- Vol. 3 (1) , 41-66
Open AccessRasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease. Once daily administration of rasagiline makes it easy to use, and allows good compliance by patients and adherence to therapy. Several multicenter studies have noted the effectiveness of rasagiline on both motor and non-motor symptoms, which require a complex pharmacologic approach, such as cognitive disorders. A recent study also reported a rapid action of rasagiline on motor symptoms. Positive findings have been highlighted by an economic model study. This review analyzes the main studies of rasagiline, with particular attention to the effectiveness of the drug on motor symptoms.
- 30 October 2013
- Published by Springer Nature in Neurological Sciences
- Vol. 35 (1) , 15-21
Neurological complications of tick borne encephalitis: the experience of 89 patients studied and literature review
Tick borne encephalitis (TBE) is an acute febrile syndrome that can be complicated with neurological symptoms ranging from mild meningitis to severe encephalomyelitis. The causative agent is a virus belonging to the family of flaviviruses. We have collected a series of 89 patients and compared the clinical course with the main data of the literature of TBE. This review in addition describes the clinical manifestations associated with TBE infections, the main molecular-biological properties of these viruses, and the different factors that define the incidence and severity of disease who are frequently situated in the age group young/adult with a social harm and functional non-negligible. This review also contains diagnostic elements and neuropathological features typical of this infection and a brief summary of vaccination against TBE.
- 30 October 2013
- Published by Springer Nature in Neurological Sciences
- Vol. 35 (1) , 15-21
Neurological complications of tick borne encephalitis: the experience of 89 patients studied and literature review
Tick borne encephalitis (TBE) is an acute febrile syndrome that can be complicated with neurological symptoms ranging from mild meningitis to severe encephalomyelitis. The causative agent is a virus belonging to the family of flaviviruses. We have collected a series of 89 patients and compared the clinical course with the main data of the literature of TBE. This review in addition describes the clinical manifestations associated with TBE infections, the main molecular-biological properties of these viruses, and the different factors that define the incidence and severity of disease who are frequently situated in the age group young/adult with a social harm and functional non-negligible. This review also contains diagnostic elements and neuropathological features typical of this infection and a brief summary of vaccination against TBE.
- 1 May 2013
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (11) , 2007-2013
Rapid onset of efficacy of rasagiline in early Parkinson’s disease
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease (PD). This naturalistic single-blind study was aimed at evaluating the rapidity of onset effect of rasagiline on motor symptoms in a cohort of early relatively elderly PD patients. 102 outpatients (55 males, median age 71 years) have been selected: 26 were PD therapy-naive and 76 received rasagiline as add-on therapy. The third section of the Unified Parkinson’s Disease Rating Scale (UPDRSIII) and the Hoehn–Yahr (HY) scale were assessed at baseline and after 1 and 4 weeks thereafter. The mean UPDRS III total score (−6.7 at week 1 and −8.9 at week 4) and single items, as well as mean HY score (−0.40 at week 1 and −0.67 at week 4), significantly decreased from baseline (p or ≤71 years. Rasagiline had a rapid therapeutic effect from the first week of therapy, which further improved at 4 weeks. The rapid onset of action and the absence of a dose titration are important issues in the management of the PD patient.
- 1 May 2013
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (11) , 2007-2013
Rapid onset of efficacy of rasagiline in early Parkinson’s disease
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease (PD). This naturalistic single-blind study was aimed at evaluating the rapidity of onset effect of rasagiline on motor symptoms in a cohort of early relatively elderly PD patients. 102 outpatients (55 males, median age 71 years) have been selected: 26 were PD therapy-naive and 76 received rasagiline as add-on therapy. The third section of the Unified Parkinson’s Disease Rating Scale (UPDRSIII) and the Hoehn–Yahr (HY) scale were assessed at baseline and after 1 and 4 weeks thereafter. The mean UPDRS III total score (−6.7 at week 1 and −8.9 at week 4) and single items, as well as mean HY score (−0.40 at week 1 and −0.67 at week 4), significantly decreased from baseline (p or ≤71 years. Rasagiline had a rapid therapeutic effect from the first week of therapy, which further improved at 4 weeks. The rapid onset of action and the absence of a dose titration are important issues in the management of the PD patient.
- 1 July 2012
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 35 (4) , 185-190
A Systematic Review of Catechol-O-Methyltransferase Inhibitors
Catechol-O-methyltransferase (COMT) inhibitors are drugs commonly used in the management of patients with Parkinson disease complicated by motor fluctuations. Among them, entacapone is the most commonly used. Tolcapone has been reintroduced in patients where entacapone has proved to be ineffective after being withdrawn from the market because of sporadic cases of hepatotoxicity. The last COMT inhibitor is nebicapone, which use in clinical practice is still under study. The objectives of this study were to analyze the clinical efficacy in reducing motor complications and to evaluate their use in clinical practice and the adverse events reported in the literature. Scientific articles of the main previously mentioned drugs have been reviewed. All these 3 drugs have proved to be effective in improving wearing-off and significantly reduce the daily dose of levodopa at the number of daily intakes. Tolcapone is undoubtedly the most effective drug, although in clinical practice sporadic cases of hepatotoxicity have limited its use in patients unresponsive to entacapone. Nebicapone is effective, and its safety is still under evaluation. Entacapone is generally well tolerated, and no significant adverse events are reported. To manage motor fluctuations, the use of COMT inhibitors is now consolidated in the common clinical practice. Tolcapone is used as a second choice in patients with severe motor fluctuations not responsive to entacapone.
- 1 July 2012
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 35 (4) , 185-190
A Systematic Review of Catechol-O-Methyltransferase Inhibitors
Catechol-O-methyltransferase (COMT) inhibitors are drugs commonly used in the management of patients with Parkinson disease complicated by motor fluctuations. Among them, entacapone is the most commonly used. Tolcapone has been reintroduced in patients where entacapone has proved to be ineffective after being withdrawn from the market because of sporadic cases of hepatotoxicity. The last COMT inhibitor is nebicapone, which use in clinical practice is still under study. The objectives of this study were to analyze the clinical efficacy in reducing motor complications and to evaluate their use in clinical practice and the adverse events reported in the literature. Scientific articles of the main previously mentioned drugs have been reviewed. All these 3 drugs have proved to be effective in improving wearing-off and significantly reduce the daily dose of levodopa at the number of daily intakes. Tolcapone is undoubtedly the most effective drug, although in clinical practice sporadic cases of hepatotoxicity have limited its use in patients unresponsive to entacapone. Nebicapone is effective, and its safety is still under evaluation. Entacapone is generally well tolerated, and no significant adverse events are reported. To manage motor fluctuations, the use of COMT inhibitors is now consolidated in the common clinical practice. Tolcapone is used as a second choice in patients with severe motor fluctuations not responsive to entacapone.
- 6 November 2011
- Published by Springer Nature in Neurological Sciences
- Vol. 33 (3) , 669-672
Isolated polio-like syndrome after tick-borne encephalitis presenting with acute hyperckemia
Tick borne encephalitis virus infection usually shows a biphasic course. In the first stage of illness symptoms are similar to a flu-like syndrome, then after a defervescence period, fever may represent with neurological manifestations ranging from mild meningitis to severe encephalomyelitis. We report the clinical case of an adult man presented with an acute proximal hyposthenia, severe hyperckemia, clinical and laboratoristic evidence of acute tick borne virus infection. This virus has a favourite tropism for the anterior horn cells of the cervical spine segment. Polio-like syndrome, usually affecting the upper limbs, is the clinical phenotype of an infection of the cervical motoneurons. Usually myelitis is associated to severe encephalitis and a complete diagnosis may be difficult in comatose patients. Rarely, an isolated polio-like syndrome may be the sole neurological complication of tick-borne encephalitis.
- 6 November 2011
- Published by Springer Nature in Neurological Sciences
- Vol. 33 (3) , 669-672
Isolated polio-like syndrome after tick-borne encephalitis presenting with acute hyperckemia
Tick borne encephalitis virus infection usually shows a biphasic course. In the first stage of illness symptoms are similar to a flu-like syndrome, then after a defervescence period, fever may represent with neurological manifestations ranging from mild meningitis to severe encephalomyelitis. We report the clinical case of an adult man presented with an acute proximal hyposthenia, severe hyperckemia, clinical and laboratoristic evidence of acute tick borne virus infection. This virus has a favourite tropism for the anterior horn cells of the cervical spine segment. Polio-like syndrome, usually affecting the upper limbs, is the clinical phenotype of an infection of the cervical motoneurons. Usually myelitis is associated to severe encephalitis and a complete diagnosis may be difficult in comatose patients. Rarely, an isolated polio-like syndrome may be the sole neurological complication of tick-borne encephalitis.